Systemic Microvascular Function in Patients With Resistant Hypertension After Renal Sympathetic Denervation
NCT ID: NCT03243045
Last Updated: 2020-01-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2017-03-01
2020-01-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The present study aimed to investigate the influence of the renal sympathetic denervation on the skin microvascular function of patients presenting with resistant arterial hypertension.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Renal Denervation in End Staged Renal Disease With Resistant Hypertension
NCT02346045
Sympathetic Renal Denervation Versus Increment of Pharmacological Treatment in Resistant Arterial Hypertension.
NCT02039492
Evaluation of Systemic Microvascular Reactivity in Patients With Resistant Hypertension
NCT05464849
Renal Sympathetic Denervation as a New Treatment for Therapy Resistant Hypertension
NCT01850901
Sympathetic Activity and Renal Denervation
NCT01355055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The present study aimed to investigate the influence of the renal sympathetic denervation on the skin microvascular function of patients with resistant hypertension.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Renal sympathetic denervation
Transcutaneous renal sympathetic denervation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* renal dysfunction
* severe kidney disease
* congestive heart failure
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Cardiology, Laranjeiras, Brazil
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eduardo Tibirica, MD, PhD
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
EDUARDO V TIBIRICA, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
National Innstitute of Cardiology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Cardiology
Rio de Janeiro, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAAE-51310815.0.0000.5272
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.